Table 1. Study population.

	All Gender	Gender		Tested post vaccination			Vaccine
Age group (y)	Nr	M	F	Nr	M	F	BNT162b2 (1 dose)	AZD1222 (1 dose)
19–29	456	145	311	429	138	291	354 (10)	56 (12)
30–39	510	193	317	483	185	298	424 (11)	39 (14)
40–49	547	161	386	531	158	373	488 (12)	24 (10)
50–59	451	155	296	432	153	279	406 (10)	9 (12)
60–69	132	56	76	130	55	75	122 (5)	4 (0)
70–81	25	17	8	24	16	8	24 (0)	1 (0)
Total Nr	2121	727	1394	2029	705	1324	1818 (48)	133 (48)